Intermediate stage treatment: Is TACE enough?

Liver Int. 2018 Jan;38(1):187. doi: 10.1111/liv.13598. Epub 2017 Oct 23.

Authors

Xavier Adhoute¹, Guillaume Penaranda², Jean Luc Raoul³, Marc Bourlière¹

Affiliations

¹ Department of Hepato-Gastroenterology, Hôpital Saint-Joseph, Marseille, France.
² AlphaBio Laboratory, Marseille, France.
³ Department of Hepato-Gastroenterology and Digestive Oncology, Institut Paoli-Calmette, Marseille, France.

PMID: 28952186
DOI: 10.1111/liv.13598

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular*
Chemoembolization, Therapeutic*
Humans
Liver Neoplasms
Neoplasm Staging
Treatment Outcome